Fujifilm to Establish New Manufacturing and Innovation Center in Massachusetts
The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products.
Fujifilm and The Massachusetts Center for Advanced Biological Innovation and Manufacturing announced on Jan. 14, 2021 that they are investing $76 million into a new manufacturing and innovation center in Watertown, MA.
The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products, Fujifilm said in a company press release. The site will all also provide quality control, lab, office, and convening space for academia, industries, and hospitals.
Operations at the center will begin in early 2022.
“Fujifilm is pleased to partner with leading academia, industry, and teaching hospitals, to explore the application of genetically modified cell therapies, and bring new treatment options to the market,” said Takatoshi Ishikawa, senior executive vice-president and chief life science officer, Fujifilm, in the press release. “This collaboration supports our larger healthcare strategy to utilize the combined strength of the Fujifilm Group’s products and services to offer personalized life-altering treatment options to clinicians and their patients.”
Source: Fujifilm Corporation
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
